-
Health inequity may drive higher symptom burden in childhood cancer survivors
09/27/2022
Findings from St. Jude Children’s Research Hospital reveal that childhood cancer survivors with disadvantaged socio-demographic factors are over 7 times more likely to experience severe symptom burdens.
-
St. Jude finds a new way to identify ‘safe harbor’ for gene therapies
09/22/2022
A tool created by St. Jude scientists may increase the safety of gene and cell therapy by finding safe places to add genes to human DNA.
-
Family ties: Inherited genetic variants increase risk of Hodgkin lymphoma
09/08/2022
St. Jude scientists have completed the largest study of families affected by Hodgkin lymphoma and identified novel variants linked to cancer predisposition.
-
To wipe childhood cancer off the map, scientists must chart its genomic landscape
09/01/2022
St. Jude scientists sequenced the most childhood cancer samples from a single cancer type ever in a landmark study.
-
SAFER Ukraine provides a blueprint for responding to global health crises
08/30/2022
St. Jude Global and partners help Ukrainian children with cancer and blood disorders continue treatment, creating a model for responses to other crises.
-
New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab
08/24/2022
St. Jude scientists created an LCK targeted PROTAC able to kill T-cell acute lymphoblastic leukemia cells.
-
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia
08/05/2022
St. Jude scientists developed a simple method to select for more effective cancer-destroying CAR T cells to treat T-ALL.
-
Getting more mileage from a T-cell therapy for AML
07/28/2022
St. Jude scientists have created a proof-of-principle approach to improve engager T-cell therapy for difficult-to-treat acute myeloid leukemia.
-
Frank Fazio named president of Children's GMP and vice president of therapeutics production and quality at St. Jude
07/27/2022
The Good Manufacturing Practices (GMP) facility produces highly specialized biopharmaceuticals and other biological products for the hospital’s clinics.
-
Genetics weigh heavy on childhood cancer survivors’ risk of developing obesity
07/25/2022
St. Jude scientists created a way to identify childhood cancer patients at diagnosis who are at the highest risk for developing severe obesity as adults.
Explore more research news
More Research News
-
Scientific Report 2021
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.